Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

Study Identifier:

31-14-204

ClinicalTrials.gov Identifier:

NCT03661983

EudraCT Identifier:

2018-002270-48

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Study Contact Information:

N/A

Terminated/Withdrawn

Subscribe to Updates

Results Available

Study Protocol

Available Languages: English

Download document(s)

Statistical Analysis Plan

Available Languages: English

Download document(s)

Study Details

Medical Condition

Tourette's Disorder

Study Drug

Drug: Aripiprazole
Drug: Placebo

Date

Oct 2018 - Jun 2020

Phase 1

Phase 2

Phase 3

Phase 4

N/A

Patient Requirements

Sex: Female & Male

Age: 6 - 17 Years

Requirements Information

Protocol Summary

To evaluate the long-term efficacy of oral aripiprazole in pediatric participants for the treatment of Tourette's Disorder (TD).

Study Locations

Location

Status

Location

Advanced Research Center

Anaheim, California, United States, 92805

Status

N/A

Location

CT Trials - Riverside

Riverside, California, United States, 92506

Status

N/A

Location

Syrentis Clinical Research

Santa Ana, California, United States, 92705

Status

N/A

Location

Comprehensive Research Center

Norwich, Connecticut, United States, 06360

Status

N/A

Location

Sarkis Clinical

Gainesville, Florida, United States, 32607

Status

N/A

Location

Reliable Clinical Research

Hialeah, Florida, United States, 33012

Status

N/A